Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential.
Portland,Oregon (PRWEB UK) 13 January 2015
The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential. Emphasis on restricting access to controlled drugs is much higher in emerging markets than in developed nations, resulting in a level of consumption that is too low to meet pain-control requirements even in cases of terminal illness. There is a high level of unmet need for pain control in both cancer and HIV/AIDS, and serious concerns have been raised regarding inadequate pain management in the emerging markets.
However, this is expected to change in the near future as regulatory authorities attempt to remedy the situation. Indeed, several new developments promise a better outlook for future access. Although India currently has a minor share of the market, it is expected to post a high growth rate (21.3% by 2023) due to improved access to opioid analgesics. Similarly, consumption in Brazil and Argentina is also expected to increase due to recent changes to their palliative care policies. Although the opioids market in emerging countries is small, it is expected to grow at a faster pace in forecast period than in some developed countries.
Opioids in Emerging Markets covers"" the major emerging markets of Argentina, Brazil, China, India, Mexico, Russia, and South Africa, and includes
Discussion of the key challenges that restrict opioid use in pain management
Analysis of the inadequate use of opioids in pain control and the associated unmet need
Discussion of the key changes in the regulatory and legal landscape that affect opioids, prescription barriers, palliative care, and harm-reduction activities
Analysis of recent developments in emerging markets and their expected impact on opioid accessibility and usage
Country snapshots, which include key regulations, consumption, market revenues and forecasts, and key drivers and barriers in India, Brazil and South Africa
Snapshot of consumption trends along with market revenues and forecasts in Argentina and China
Key Reasons to Purchase
Understand the key constraints in emerging markets that limit the use of opioids in pain management
Understand recent changes in the regulatory environment and gauge their impact on opioid usage
Gain perspective on the unmet need in the opioids market
Understand the market size and growth potential in emerging markets and identify high-potential countries for opioid products
Enquiry of this report: http://www.bigmarketresearch.com/report-enquiry/159517
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Direct :+1 (617) 674-4143
Toll Free : +1 (855) 711-1555
Fax : +1 (855) 550-5975